Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve the Audited Financial ....
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Torrent Pharmaceuticals has notified exchanges that its Board of Directors will meet on 22 May 2026 to consider and approve the Audited Financial Results for the year ended 31 March 2026. The meeting will also consider recommending a final dividend for FY 2025-26. Additionally, the Board will seek enabling resolutions for raising funds through equity shares, convertible bonds/debentures via Qualified Institutional Placement (QIP), depository receipts, or other modes, subject to shareholder approval at the AGM. This is a routine regulatory intimation under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The meeting could lead to positive sentiment if the company reports strong FY26 results and declares a dividend. The fund-raising authorization indicates potential equity dilution in the future, which investors should monitor. No immediate impact until actual results and dividend details are announced.